Ladenburg Thalmann Financial Services Inc. grew its position in Humana Inc (NYSE:HUM) by 18.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,465 shares of the insurance provider’s stock after acquiring an additional 988 shares during the quarter. Ladenburg Thalmann Financial Services Inc.’s holdings in Humana were worth $1,729,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of the company. BlackRock Inc. boosted its holdings in shares of Humana by 1.7% in the first quarter. BlackRock Inc. now owns 12,186,387 shares of the insurance provider’s stock valued at $3,276,068,000 after acquiring an additional 198,588 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Humana by 0.8% in the first quarter. Dimensional Fund Advisors LP now owns 1,564,251 shares of the insurance provider’s stock valued at $420,503,000 after acquiring an additional 11,915 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Humana by 1.9% in the fourth quarter. Geode Capital Management LLC now owns 1,522,654 shares of the insurance provider’s stock valued at $376,937,000 after acquiring an additional 28,147 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in shares of Humana by 80.1% in the first quarter. Massachusetts Financial Services Co. MA now owns 741,942 shares of the insurance provider’s stock valued at $199,454,000 after acquiring an additional 329,956 shares during the period. Finally, Old Mutual Global Investors UK Ltd. lifted its holdings in shares of Humana by 213.1% during the first quarter. Old Mutual Global Investors UK Ltd. now owns 727,057 shares of the insurance provider’s stock worth $195,454,000 after purchasing an additional 494,826 shares during the period. 93.34% of the stock is owned by institutional investors and hedge funds.
HUM has been the subject of several recent research reports. Cantor Fitzgerald reaffirmed a “hold” rating and set a $250.00 price target on shares of Humana in a report on Monday, April 23rd. Zacks Investment Research downgraded Humana from a “buy” rating to a “hold” rating in a report on Tuesday, March 13th. Argus increased their price target on Humana from $270.00 to $330.00 and gave the stock a “buy” rating in a report on Monday, April 16th. ValuEngine raised Humana from a “hold” rating to a “buy” rating in a report on Monday, April 2nd. Finally, Citigroup reaffirmed a “buy” rating and set a $340.00 price target (up from $280.00) on shares of Humana in a report on Friday, June 1st. Eight research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $286.83.
Humana opened at $299.83 on Tuesday, Marketbeat reports. The firm has a market capitalization of $41.30 billion, a price-to-earnings ratio of 24.39, a price-to-earnings-growth ratio of 1.56 and a beta of 0.92. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.55 and a quick ratio of 1.55. Humana Inc has a 1 year low of $229.84 and a 1 year high of $309.18.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, May 2nd. The insurance provider reported $3.36 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.21 by $0.15. The firm had revenue of $14.28 billion during the quarter, compared to analysts’ expectations of $14.22 billion. Humana had a return on equity of 16.74% and a net margin of 3.36%. During the same quarter in the prior year, the business posted $2.75 earnings per share. sell-side analysts anticipate that Humana Inc will post 13.99 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 27th. Shareholders of record on Friday, June 29th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.67%. The ex-dividend date of this dividend is Thursday, June 28th. Humana’s payout ratio is 17.08%.
In other Humana news, insider Heidi S. Margulis sold 20,621 shares of the stock in a transaction on Thursday, May 3rd. The stock was sold at an average price of $285.90, for a total value of $5,895,543.90. Following the completion of the transaction, the insider now owns 9,220 shares in the company, valued at $2,635,998. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Cynthia H. Zipperle sold 1,000 shares of the stock in a transaction on Wednesday, June 13th. The stock was sold at an average price of $306.01, for a total value of $306,010.00. The disclosure for this sale can be found here. Insiders sold 124,009 shares of company stock valued at $36,887,143 in the last quarter. 0.60% of the stock is currently owned by company insiders.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.